Bahrain’s Investcorp makes its first pharmaceutical investment in India with a $17.5m V-Ensure deal

This investment will fund V-Ensure’s pursuit of growth opportunities in North America, Europe and other markets for its products. V-Ensure has developed oral solid, oral liquid and injectable products for over 45 customers in Europe, North America, China, Australia and Brazil.

Gaurav Sharma, Head of Private Equity at Investcorp India, said, “As India’s first pharmaceutical deal, we are confident that global healthcare will continue to be at the center of the future. V-Ensure is a renowned name among India-based pharmaceutical research organizations.

“Investcorp’s global presence will potentially help V-Ensure as they seek to establish their presence directly in the US market.” (Investcorp has been active in the middle market private equity sector in India since 2019, investing in the healthcare, business services, financial services, consumer and retail, and technology sectors. )

Over the past 10 years, V-Ensure has maintained its position as a “contract research organization”. A team of 150 scientists and pharmaceutical development program managers for the main pharmaceutical markets.

Satyanarayana Vemula, CEO of V-Ensure, added: “With the support of Investcorp’s experienced team and global network, we believe we will be well positioned to significantly accelerate our growth.

About Margie Peters

Check Also

My day: Grainne Hughes, Almac Pharma Services

At 8am, I’m in my car and already halfway from the office to Almac’s headquarters …